Loading...

Elliott Vichinsky, MD

Title(s)Professor, Pediatrics
SchoolSchool of Medicine
Address401 Parnassus Ave.
San Francisco CA 94143
Phone--
ORCID ORCID Icon0000-0002-0500-9579 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Wisconsin, MadisonB.S. 1970Biology
    State University of New York DownstateM.D.1974School of Medicine
    Children's Orthopedic Hospital and Medical Center, Seattle, WAInternship1975Pediatrics
    Children's Orthopedic Hospital and Medical Center, Seattle, WAFellowship1978Pediatrics
    University of Washington, Seattle, WASenior Research Fellow1979Dept of Pediatrics and Medicine
    Collapse Awards and Honors
    Sickle Cell Disease Association of America (SCDAA)2013Pioneer Award
    Cooley's Anemia Foundation2009Distinguished Leadership as Chair of the Medical Advisory Board
    Sickle Cell Disease Foundation of California2007Lifetime Achievement Award
    Children's Hospital & Research Center Oakland2005Bronze Bambino Lifetime Achievement Award
    Children's Miracle Network1995Miracle Maker Award
    Alpha Omega Alpha Honor Society1974Alpha Omega Award
    State University of New York Downstate1974Cum Laude
    University of Wisconsin1970Cum Laude

    Collapse Overview 
    Collapse Overview
    I am the Director of Hematology/Oncology at UCSF Benioff Children's Hospital Oakland, Adjunct Professor at University of California San Francisco, as well as the Director of the Northern California Sickle Cell and Thalassemia Centers. I am a board-certified pediatric hematologist/oncologist with a major interest in understanding and improving the care of patients with hemoglobinopathies. My career has focused on translational research in hemoglobinopathies to answer therapeutic questions in hematologic and iron overload disorders, including iron metabolism and its consequences in multiple diseases, alloimmunization, transfusion efficacy and risks in hematology.

    Over 30 years ago, I established the hemoglobinopathy center at Children's Hospital Oakland to provide primary through tertiary care to pediatric and adult patients. I have been a federally-funded research investigator for over 30 years and national principal investigator for many successful trials -- including transfusion therapy and chelation therapy in hemoglobinopathies. I have been principal investigator or co-investigator on many of the key translational studies, including understanding the mechanism and treatment of neurologic injury in sickle cell disease; iron trafficking and iron overload in hemoglobinopathies, and new therapies to change the pathophysiology of sickle cell biology.

    I have served as Editor-in-Chief of Pediatric Hematology and Oncology; Chairman of the Thalassemia Clinical Research Network, and Director of the Cooley’s Medical Board.

    Collapse Research 
    Collapse Research Activities and Funding
    SC-Links - Linking the Sickle Cell Community, Providers and Systems to Improve Sickle Cell Disease Care
    NIH/NHLBI U01HL134007Aug 5, 2016 - Jun 30, 2022
    Role: Principal Investigator
    Phase 2 Study of Deferiprone in the Treatment of NBIA
    FDA R01FD004103Sep 15, 2012 - Aug 31, 2016
    Role: Principal Investigator
    Ninth Cooley's Anemia Symposium
    NIH/NHLBI R13HL096359Sep 1, 2009 - Aug 31, 2010
    Role: Principal Investigator
    Prevention of Complications in Thalassemia
    CDC/NCBDD U01DD000310Sep 30, 2007 - Sep 29, 2012
    Role: Principal Investigator
    Eighth Cooley's Anemia Symposium
    NIH/NHLBI R13HL079823Jan 1, 2005 - Dec 31, 2005
    Role: Principal Investigator
    Northern California Comprehensive Sickle Cell Centers
    NIH U54HL070583Jul 1, 2003 - Mar 31, 2010
    Role: Co-Investigator
    Modulation of Iron Deposition in SCD and Other Hemoglobinopathies
    NIH/NIDDK R01DK057778Aug 1, 2000 - May 31, 2006
    Role: Co-Principal Investigator
    Thalassemia Clinical Research Network
    NIH/NHLBI U01HL065239Jul 1, 2000 - Jun 30, 2011
    Role: Principal Investigator
    E/BETA THALASSEMIA--NATURAL HISTORY &RESPONSE TO CHEMO
    NIH/NHLBI R01HL061186Sep 30, 1998 - Jul 31, 2004
    Role: Principal Investigator
    PEDIATRIC COHORT OF THE CSSCD
    NIH/NHLBI N01HB047107Apr 1, 1994 - Mar 31, 1999
    Role: Principal Investigator
    SELECTED PATIENT GROUPS FROM THE CSSCD
    NIH/NHLBI N01HB097054Oct 1, 1988 - Sep 30, 1993
    Role: Principal Investigator
    PEDIATRIC CLINICAL RESEARCH CENTER
    NIH/NCRR M01RR001271Dec 1, 1981 - Sep 29, 2006
    Role: Co-Investigator
    NORTHERN CALIFORNIA COMPREHENSIVE SICKLE CELL CENTER
    NIH P60HL020985Apr 1, 1978 - Mar 31, 2004
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA Netw Open. 2020 Jul 01; 3(7):e2010874. Abrams DI, Couey P, Dixit N, Sagi V, Hagar W, Vichinsky E, Kelly ME, Connett JE, Gupta K. PMID: 32678452.
      View in: PubMed   Mentions:    Fields:    
    2. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020 Apr 28; 4(8):1554-1588. DeBaun MR, Jordan LC, King AA, Schatz J, Vichinsky E, Fox CK, McKinstry RC, Telfer P, Kraut MA, Daraz L, Kirkham FJ, Murad MH. PMID: 32298430.
      View in: PubMed   Mentions: 3     Fields:    
    3. Influence of sickle cell disease on susceptibility to HIV infection. PLoS One. 2020; 15(4):e0218880. Kelly S, Jacobs ES, Stone M, Keating SM, Lee TH, Chafets D, Heitman J, Dimapasoc M, Operskalski E, Hagar W, Vichinsky E, Busch MP, Norris PJ, Custer B. PMID: 32267841.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    4. Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2019 09; 16(9):e17-e32. Ruhl AP, Sadreameli SC, Allen JL, Bennett DP, Campbell AD, Coates TD, Diallo DA, Field JJ, Fiorino EK, Gladwin MT, Glassberg JA, Gordeuk VR, Graham LM, Greenough A, Howard J, Kato GJ, Knight-Madden J, Kopp BT, Koumbourlis AC, Lanzkron SM, Liem RI, Machado RF, Mehari A, Morris CR, Ogunlesi FO, Rosen CL, Smith-Whitley K, Tauber D, Terry N, Thein SL, Vichinsky E, Weir NA, Cohen RT, Klings ES. PMID: 31469310.
      View in: PubMed   Mentions: 2     Fields:    
    5. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Lancet Neurol. 2019 07; 18(7):631-642. Klopstock T, Tricta F, Neumayr L, Karin I, Zorzi G, Fradette C, Kmiec T, Büchner B, Steele HE, Horvath R, Chinnery PF, Basu A, Küpper C, Neuhofer C, Kálmán B, Dušek P, Yapici Z, Wilson I, Zhao F, Zibordi F, Nardocci N, Aguilar C, Hayflick SJ, Spino M, Blamire AM, Hogarth P, Vichinsky E. PMID: 31202468.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519. Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J. PMID: 31199090.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    7. Vincristine-induced anemia in hereditary spherocytosis. Exp Biol Med (Maywood). 2019 07; 244(10):850-854. Michlitsch J, Larkin S, Vichinsky E, Kuypers FA. PMID: 31161774.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Evaluation of Mandible Fractures in Patients With Sickle Cell Anemia-A Nationwide Study. J Oral Maxillofac Surg. 2019 Jul; 77(7):1418-1422. Akbari M, Patel R, Carrao V, Hagar W, Vichinsky E, Chuang SK. PMID: 30707980.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Transfusion practices and complications in thalassemia. Transfusion. 2018 12; 58(12):2826-2835. Lal A, Wong TE, Andrews J, Balasa VV, Chung JH, Forester CM, Ikeda AK, Keel SB, Pagano MB, Puthenveetil G, Shah SJ, Yu JC, Vichinsky EP. PMID: 30260477.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    10. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. N Engl J Med. 2018 Jul 19; 379(3):226-235. Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP. PMID: 30021096.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    11. Gene Therapy in Patients with Transfusion-Dependent ß-Thalassemia. N Engl J Med. 2018 04 19; 378(16):1479-1493. Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarré C, Beuzard Y, Chrétien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M. PMID: 29669226.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCellsCTClinical Trials
    12. Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States. Pediatr Blood Cancer. 2018 07; 65(7):e27067. Vichinsky E, Cohen A, Thompson AA, Giardina PJ, Lal A, Paley C, Cheng WY, McCormick N, Sasane M, Qiu Y, Kwiatkowski JL. PMID: 29637688.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia. Hematol Oncol Clin North Am. 2018 04; 32(2):297-315. Carlberg KT, Singer ST, Vichinsky EP. PMID: 29458733.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Sickle cell disease. Nat Rev Dis Primers. 2018 03 15; 4:18010. Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP. PMID: 29542687.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansPHPublic Health
    15. Dietary nonheme iron is equally bioavailable from ferritin or ferrous sulfate in thalassemia intermedia. Pediatr Hematol Oncol. 2017 Nov; 34(8):455-467. Khurana M, Fung EB, Vichinsky EP, Theil EC. PMID: 29232169.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Chronic organ failure in adult sickle cell disease. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):435-439. Vichinsky E. PMID: 29222290.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    17. Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors. Blood Cells Mol Dis. 2018 05; 70:66-77. Serjeant GR, Vichinsky E. PMID: 28689691.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    18. Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience. Pediatr Hematol Oncol. 2017 Mar; 34(2):100-106. Winstead M, Sun PP, Martin K, Earl J, Neumayr L, Hoppe C, Vichinsky E. PMID: 28532265.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    19. Lifespan care in SCD: Whom to transition, the patients or the health care system? Am J Hematol. 2017 Jun; 92(6):487-489. Minniti CP, Vichinsky E. PMID: 28211097.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial. Br J Haematol. 2017 05; 177(4):620-629. Hoppe C, Jacob E, Styles L, Kuypers F, Larkin S, Vichinsky E. PMID: 28369718.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    21. Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST). Pediatr Blood Cancer. 2017 Sep; 64(9). Vichinsky E, El-Beshlawy A, Al Zoebie A, Kamdem A, Koussa S, Chotsampancharoen T, Bruederle A, Gilotti G, Han J, Elalfy M. PMID: 28296163.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease. PLoS One. 2017; 12(2):e0171067. Field JJ, Majerus E, Ataga KI, Vichinsky EP, Schaub R, Mashal R, Nathan DG. PMID: 28152086.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    23. Emergency department utilization by Californians with sickle cell disease, 2005-2014. Pediatr Blood Cancer. 2017 06; 64(6). Paulukonis ST, Feuchtbaum LB, Coates TD, Neumayr LD, Treadwell MJ, Vichinsky EP, Hulihan MM. PMID: 28000344.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature. Prenat Diagn. 2016 Dec; 36(13):1242-1249. Kreger EM, Singer ST, Witt RG, Sweeters N, Lianoglou B, Lal A, Mackenzie TC, Vichinsky E. PMID: 27862048.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Stroke recurrence in adult sickle cell patients: it is time for action! Transfusion. 2016 05; 56(5):1001-4. Neumayr L, Vichinsky E. PMID: 27167352.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    26. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management. Curr Med Res Opin. 2016; 32(1):191-204. Vichinsky E. PMID: 26479125.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axis. Am J Hematol. 2015 Sep; 90(9):E190-2. Singer ST, Killilea D, Suh JH, Wang ZJ, Yuan Q, Ivani K, Evans P, Vichinsky E, Fischer R, Smith JF. PMID: 26044409.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia. Br J Haematol. 2015 Jun; 169(6):887-98. Morris CR, Kim HY, Klings ES, Wood J, Porter JB, Trachtenberg F, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, Hassell K, Taher A, Neufeld EJ, Thompson AA, Larkin S, Suh JH, Vichinsky EP, Kuypers FA. PMID: 25907665.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    29. Is the medical home for adult patients with sickle cell disease a reality or an illusion? Hemoglobin. 2015; 39(2):130-3. Ballas SK, Vichinsky EP. PMID: 25806421.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    30. In utero hematopoietic cell transplantation for hemoglobinopathies. Front Pharmacol. 2014; 5:278. Derderian SC, Jeanty C, Walters MC, Vichinsky E, MacKenzie TC. PMID: 25628564.
      View in: PubMed   Mentions:
    31. Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients. Br J Haematol. 2014 Dec; 167(5):692-6. Porter JB, Walter PB, Neumayr LD, Evans P, Bansal S, Garbowski M, Weyhmiller MG, Harmatz PR, Wood JC, Miller JL, Byrnes C, Weiss G, Seifert M, Grosse R, Grabowski D, Schmidt A, Fischer R, Nielsen P, Niemeyer C, Vichinsky E. PMID: 25209728.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    32. Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH). Pediatr Blood Cancer. 2014 Dec; 61(12):2271-6. Paulukonis ST, Harris WT, Coates TD, Neumayr L, Treadwell M, Vichinsky E, Feuchtbaum LB. PMID: 25176145.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    33. Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease. Hematology/Oncology Clinics of North America. 2014; 155-414. Vichinsky, Elliott P., ed.View Publication.
    34. Relationship among chelator adherence, change in chelators, and quality of life in thalassemia. Qual Life Res. 2014 Oct; 23(8):2277-88. Trachtenberg FL, Gerstenberger E, Xu Y, Mednick L, Sobota A, Ware H, Thompson AA, Neufeld EJ, Yamashita R. PMID: 24682717.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    35. Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy. Ann Hematol. 2014 Jul; 93(7):1139-48. Singer ST, Kuypers F, Fineman J, Gildengorin G, Larkin S, Sweeters N, Rosenfeld H, Kurio G, Higa A, Jeng M, Huang J, Vichinsky EP. PMID: 24577514.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology. 2014 Mar 11; 82(10):835-41. Mackin RS, Insel P, Truran D, Vichinsky EP, Neumayr LD, Armstrong FD, Gold JI, Kesler K, Brewer J, Weiner MW. PMID: 24523480.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    37. Response to "efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up " Haematologica 2014;99(2):e17-18. Haematologica. 2014 Feb; 99(2):e19. Klings ES, Vichinsky EP, Morris CR. PMID: 24497564.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Emerging therapy in hemoglobinopathies: lessons from the past and optimism for the future. Hematol Oncol Clin North Am. 2014 Apr; 28(2):xiii-xviii. Vichinsky EP. PMID: 24589274.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major. Br J Haematol. 2014 Feb; 164(3):431-7. Klaassen RJ, Barrowman N, Merelles-Pulcini M, Vichinsky EP, Sweeters N, Kirby-Allen M, Neufeld EJ, Kwiatkowski JL, Wu J, Vickars L, Blanchette VS, Forgie M, Yamashita R, Wong-Rieger D, Young NL. PMID: 24180641.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Pain over time and its effects on life in thalassemia. Am J Hematol. 2013 Nov; 88(11):939-43. Oliveros O, Trachtenberg F, Haines D, Gerstenberger E, Martin M, Carson S, Green S, Calamaras D, Hess P, Yamashita R, Vichinsky E. PMID: 23918696.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    41. Renal medullary carcinoma in an adolescent with sickle cell anemia. Pediatr Blood Cancer. 2014 Mar; 61(3):567. Marsh A, Golden C, Hoppe C, Quirolo K, Vichinsky E. PMID: 24108577.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Efficacy and safety of deferasirox compared with deferoxamine in sickle cell disease: two-year results including pharmacokinetics and concomitant hydroxyurea. Am J Hematol. 2013 Dec; 88(12):1068-73. Vichinsky E, Torres M, Minniti CP, Barrette S, Habr D, Zhang Y, Files B. PMID: 23946212.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    43. Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2013 Oct; 98(4):960-71. Fung EB, Kwiatkowski JL, Huang JN, Gildengorin G, King JC, Vichinsky EP. PMID: 23945720.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    44. Treatment of classic pantothenate kinase-associated neurodegeneration with deferiprone and intrathecal baclofen. Am J Phys Med Rehabil. 2013 Aug; 92(8):728-33. Pratini NR, Sweeters N, Vichinsky E, Neufeld JA. PMID: 23370589.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion. 2014 Apr; 54(4):972-81; quiz 971. Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, Boudreaux J, Neufeld EJ, Kenney K, Grant A, Thompson AA. PMID: 23889533.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    46. Pregnancy outcomes in women with thalassemia in North America and the United Kingdom. Am J Hematol. 2013 Sep; 88(9):771-3. Thompson AA, Kim HY, Singer ST, Vichinsky E, Eile J, Yamashita R, Giardina PJ, Olivieri N, Parmar N, Trachtenberg F, Neufeld EJ, Kwiatkowski JL. PMID: 23757266.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Non-transfusion-dependent thalassemias. Haematologica. 2013 Jun; 98(6):833-44. Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA. PMID: 23729725.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    48. Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone. J Cardiovasc Magn Reson. 2013 May 20; 15:38. Porter JB, Wood J, Olivieri N, Vichinsky EP, Taher A, Neufeld E, Giardina P, Thompson A, Moore B, Evans P, Kim HY, Macklin EA, Trachtenberg F. PMID: 23688265.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    49. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica. 2013 Sep; 98(9):1375-82. Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP. PMID: 23645695.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    50. Clinical manifestations of a-thalassemia. Cold Spring Harb Perspect Med. 2013 May 01; 3(5):a011742. Vichinsky EP. PMID: 23543077.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    51. The palatability and tolerability of deferasirox taken with different beverages or foods. Pediatr Blood Cancer. 2013 Sep; 60(9):1507-12. Goldberg SL, Giardina PJ, Chirnomas D, Esposito J, Paley C, Vichinsky E. PMID: 23637051.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    52. Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica. 2013 Sep; 98(9):1359-67. Morris CR, Kim HY, Wood J, Porter JB, Klings ES, Trachtenberg FL, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, Singer ST, Taher A, Neufeld EJ, Thompson AA, Sachdev V, Larkin S, Suh JH, Kuypers FA, Vichinsky EP. PMID: 23585527.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    53. Application of multiplex ligation-dependent probe amplification to screen for ß-globin cluster deletions: detection of two novel deletions in a multi ethnic population. Hemoglobin. 2013; 37(3):241-56. Cui J, Azimi M, Baysdorfer C, Vichinsky EP, Hoppe CC. PMID: 23577918.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    54. Human T cell lymphotropic virus type 1 infection among U.S. thalassemia patients. AIDS Res Hum Retroviruses. 2013 Jul; 29(7):1006-9. Switzer WM, Shankar A, Trimble SR, Thompson AA, Giardina PJ, Cohen AR, Coates TD, Vichinsky E, Neufeld EJ, Boudreaux JM, Heneine W. PMID: 23409829.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Pain in thalassaemia: the effects of age on pain frequency and severity. Br J Haematol. 2013 Mar; 160(5):680-7. Haines D, Martin M, Carson S, Oliveros O, Green S, Coates T, Eile J, Schilling L, Dinu B, Mendoza T, Gerstenberger E, Trachtenberg F, Vichinsky E. PMID: 23278768.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    56. Increased leucocyte apoptosis in transfused ß-thalassaemia patients. Br J Haematol. 2013 Feb; 160(3):399-403. Walter PB, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Coates T, Giardina PJ, Grady RW, Vichinsky E, Olivieri N, Trachtenberg F, Alberti D, Fung E, Ames B, Higa A, Harmatz P. PMID: 23216540.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    57. Combined chelation therapy with deferasirox and deferoxamine in thalassemia. Blood Cells Mol Dis. 2013 Feb; 50(2):99-104. Lal A, Porter J, Sweeters N, Ng V, Evans P, Neumayr L, Kurio G, Harmatz P, Vichinsky E. PMID: 23151373.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    58. The effect of whole body vibration therapy on bone density in patients with thalassemia: a pilot study. Am J Hematol. 2012 Oct; 87(10):E76-9. Fung EB, Gariepy CA, Sawyer AJ, Higa A, Vichinsky EP. PMID: 22886910.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    59. A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2012 Nov; 87(11):1017-21. Kutlar A, Ataga K, Reid M, Vichinsky EP, Neumayr L, Blair-Britt L, Labotka R, Glass J, Keefer JR, Wargin WA, Berenson R, Perrine SP. PMID: 22887019.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    60. Inadequate dietary intake in patients with thalassemia. J Acad Nutr Diet. 2012 Jul; 112(7):980-90. Fung EB, Xu Y, Trachtenberg F, Odame I, Kwiatkowski JL, Neufeld EJ, Thompson AA, Boudreaux J, Quinn CT, Vichinsky EP. PMID: 22551675.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions. Transfusion. 2012 Dec; 52(12):2671-6. Wahl SK, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E. PMID: 22519830.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    62. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am J Hematol. 2012 May; 87(5):536-9. Kutlar A, Ataga KI, McMahon L, Howard J, Galacteros F, Hagar W, Vichinsky E, Cheung AT, Matsui N, Embury SH. PMID: 22488107.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    63. Advances in the treatment of alpha-thalassemia. Blood Rev. 2012 Apr; 26 Suppl 1:S31-4. Vichinsky E. PMID: 22631041.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    64. Identification of three novel Hb F variants: Hb F-Hayward [G?1(NA1)Gly?Asp, GGT>GAT], Hb F-Chori-I [A?T16(A13)Gly?Asp, GGC>GAC] and Hb F-Chori-II [A?I29(B11)Gly?Glu, GGA>GAA]. Hemoglobin. 2012; 36(3):305-9. Cui J, Baysdorfer C, Azimi M, Vichinsky EP, Hoppe CC. PMID: 22384921.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    65. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012 May 17; 119(20):4587-96. DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ. PMID: 22354000.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    66. British Journal of Haematology. Safety of deferasirox in sickle cell disease patients with co-existing liver impairment – response to Sinakos et al. 2012; 157(4):506–507. Vichinsky E.. View Publication.
    67. Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort. Blood. 2012 Mar 22; 119(12):2746-53. Kwiatkowski JL, Kim HY, Thompson AA, Quinn CT, Mueller BU, Odame I, Giardina PJ, Vichinsky EP, Boudreaux JM, Cohen AR, Porter JB, Coates T, Olivieri NF, Neufeld EJ. PMID: 22279056.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    68. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells. Immunohematology. 2012; 28(1):20-3. Vichinsky EP. PMID: 22646146.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    69. Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine. Hematology Am Soc Hematol Educ Program. 2012; 2012:271-5. Vichinsky E. PMID: 23233591.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    70. Hb E/beta-thalassaemia: a common & clinically diverse disorder. Indian J Med Res. 2011 Oct; 134:522-31. Olivieri NF, Pakbaz Z, Vichinsky E. PMID: 22089616.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    71. Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. Blood. 2011 Oct 06; 118(14):3794-802. Morris CR, Kim HY, Trachtenberg F, Wood J, Quinn CT, Sweeters N, Kwiatkowski JL, Thompson AA, Giardina PJ, Boudreaux J, Olivieri NF, Porter JB, Neufeld EJ, Vichinsky EP. PMID: 21772051.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    72. Reproductive capacity in iron overloaded women with thalassemia major. Blood. 2011 Sep 08; 118(10):2878-81. Singer ST, Vichinsky EP, Gildengorin G, van Disseldorp J, Rosen M, Cedars MI. PMID: 21757620.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    73. A pilot study of subcutaneous decitabine in ß-thalassemia intermedia. Blood. 2011 Sep 08; 118(10):2708-11. Olivieri NF, Saunthararajah Y, Thayalasuthan V, Kwiatkowski J, Ware RE, Kuypers FA, Kim HY, Trachtenberg FL, Vichinsky EP. PMID: 21700776.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    74. Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. Br J Haematol. 2011 Aug; 154(3):387-97. Vichinsky E, Bernaudin F, Forni GL, Gardner R, Hassell K, Heeney MM, Inusa B, Kutlar A, Lane P, Mathias L, Porter J, Tebbi C, Wilson F, Griffel L, Deng W, Giannone V, Coates T. PMID: 21592110.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    75. Iron chelation adherence to deferoxamine and deferasirox in thalassemia. Am J Hematol. 2011 May; 86(5):433-6. Trachtenberg F, Vichinsky E, Haines D, Pakbaz Z, Mednick L, Sobota A, Kwiatkowski J, Thompson AA, Porter J, Coates T, Giardina PJ, Olivieri N, Yamashita R, Neufeld EJ. PMID: 21523808.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    76. Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. Br J Haematol. 2011 Jul; 154(2):281-4. Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E. PMID: 21496003.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    77. A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol. 2011 Jun; 153(5):655-63. Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles L. PMID: 21477202.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    78. Characterization of low bone mass in young patients with thalassemia by DXA, pQCT and markers of bone turnover. Bone. 2011 Jun 01; 48(6):1305-12. Fung EB, Vichinsky EP, Kwiatkowski JL, Huang J, Bachrach LK, Sawyer AJ, Zemel BS. PMID: 21443975.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    79. The mediating effects of family functioning on psychosocial outcomes in healthy siblings of children with sickle cell disease. Pediatr Blood Cancer. 2011 Dec 01; 57(6):1055-61. Gold JI, Treadwell M, Weissman L, Vichinsky E. PMID: 21360652.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    80. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011 Feb 24; 364(8):710-8. Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP. PMID: 21345100.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    81. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol. 2011 Apr; 153(1):121-8. Thompson AA, Cunningham MJ, Singer ST, Neufeld EJ, Vichinsky E, Yamashita R, Giardina P, Kim HY, Trachtenberg F, Kwiatkowski JL. PMID: 21323889.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    82. The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial. British Journal of Haematology. 2011; 152(6):771–776. Wang, W., Brugnara, C., Snyder, C., Wynn, L., Rogers, Z., Kalinyak, K., Brown, C., Qureshi, A., Bigelow, C., Neumayr, L., Smith-Whitley, K., Chui, D. H. K., Delahunty, M., Woolson, R., Steinberg, M., Telen, M. and Kesler, K.View Publication.
    83. Novel influenza A (H1N1) viral infection in pediatric patients with sickle-cell disease. Pediatr Blood Cancer. 2011 Jan; 56(1):95-8. Jacobs JE, Quirolo K, Vichinsky E. PMID: 20973097.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    84. A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload. Haematologica. 2011 Apr; 96(4):521-5. Rienhoff HY, Viprakasit V, Tay L, Harmatz P, Vichinsky E, Chirnomas D, Kwiatkowski JL, Tapper A, Kramer W, Porter JB, Neufeld EJ. PMID: 21173101.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    85. HbE/ß-thalassemia: basis of marked clinical diversity. Hematol Oncol Clin North Am. 2010 Dec; 24(6):1055-70. Olivieri NF, Pakbaz Z, Vichinsky E. PMID: 21075280.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    86. Chart Card: feasibility of a tool for improving emergency department care in sickle cell disease. J Natl Med Assoc. 2010 Nov; 102(11):1017-23. Neumayr L, Pringle S, Giles S, Quirolo KC, Paulukonis S, Vichinsky EP, Treadwell MJ. PMID: 21141289.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    87. Education and employment status of children and adults with thalassemia in North America. Pediatr Blood Cancer. 2010 Oct; 55(4):678-83. Pakbaz Z, Treadwell M, Kim HY, Trachtenberg F, Parmar N, Kwiatkowski JL, Cunningham MJ, Martin M, Sweeters N, Neufeld EJ, Giardina PJ, Olivieri N, Yamashita RC, Vichinsky E. PMID: 20535817.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    88. Pulmonary hypertension and NO in sickle cell. Blood. 2010 Aug 05; 116(5):852-4. Gladwin MT, Barst RJ, Castro OL, Gordeuk VR, Hillery CA, Kato GJ, Kim-Shapiro DB, Machado R, Morris CR, Steinberg MH, Vichinsky EP. PMID: 20688967.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimals
    89. Preface to Cooley's Anemia: Ninth Symposium. Ann N Y Acad Sci. 2010 Aug; 1202:ix-x. Vichinsky EP, Neufeld EJ. PMID: 20712763.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    90. Fertility potential in thalassemia major women: current findings and future diagnostic tools. Ann N Y Acad Sci. 2010 Aug; 1202:226-30. Singer ST, Sweeters N, Vega O, Higa A, Vichinsky E, Cedars M. PMID: 20712797.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    91. Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy. Ann N Y Acad Sci. 2010 Aug; 1202:180-7. Vichinsky E. PMID: 20712791.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    92. Pulmonary hypertension in thalassemia. Ann N Y Acad Sci. 2010 Aug; 1202:205-13. Morris CR, Vichinsky EP. PMID: 20712794.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    93. Transfusion and chelation practices in sickle cell disease: a regional perspective. Pediatr Hematol Oncol. 2011 Mar; 28(2):124-33. Vichinsky EP, Ohene-Frempong K, Thein SL, Lobo CL, Inati A, Thompson AA, Smith-Whitley K, Kwiatkowski JL, Swerdlow PS, Porter JB, Marks PW. PMID: 20673030.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    94. Approaches to transfusion therapy and iron overload in patients with sickle cell disease: results of an international survey. Pediatr Hematol Oncol. 2011 Feb; 28(1):37-42. Vichinsky EP, Ohene-Frempong K. PMID: 20673029.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    95. Relationship between chronic transfusion therapy and body composition in subjects with thalassemia. J Pediatr. 2010 Oct; 157(4):641-7, 647.e1-2. Fung EB, Xu Y, Kwiatkowski JL, Vogiatzi MG, Neufeld E, Olivieri N, Vichinsky EP, Giardina PJ. PMID: 20547400.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    96. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA. 2010 May 12; 303(18):1823-31. Vichinsky EP, Neumayr LD, Gold JI, Weiner MW, Rule RR, Truran D, Kasten J, Eggleston B, Kesler K, McMahon L, Orringer EP, Harrington T, Kalinyak K, De Castro LM, Kutlar A, Rutherford CJ, Johnson C, Bessman JD, Jordan LB, Armstrong FD. PMID: 20460621.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    97. Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy. Pediatr Hematol Oncol. 2010 Mar; 27(2):112-21. James EB, Vreman HJ, Wong RJ, Stevenson DK, Vichinsky E, Schumacher L, Hall JY, Simon J, Golden DW, Harmatz P. PMID: 20201692.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    98. Pulmonary hypertension in hemolytic anemias. F1000 Med Rep. 2010 Feb 11; 2. Wahl S, Vichinsky E. PMID: 20948876.
      View in: PubMed   Mentions:
    99. Hemoglobin Hakkari: an autosomal dominant form of beta thalassemia with inclusion bodies arising from de novo mutation in exon 2 of beta globin gene. Pediatr Blood Cancer. 2010 Feb; 54(2):332-5. Kanathezhath B, Hazard FK, Guo H, Kidd J, Azimi M, Kuypers FA, Vichinsky EP, Lal A. PMID: 19852066.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    100. Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia. Magn Reson Imaging. 2010 Apr; 28(3):363-71. Wang ZJ, Fischer R, Chu Z, Mahoney DH, Mueller BU, Muthupillai R, James EB, Krishnamurthy R, Chung T, Padua E, Vichinsky E, Harmatz P. PMID: 20061110.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    101. Low dose, oral epsilon aminocaproic acid for renal papillary necrosis and massive hemorrhage in hemoglobin SC disease. Pediatr Blood Cancer. 2010 Jan; 54(1):148-50. Gabrovsky A, Aderinto A, Aderinto A, Spevak M, Vichinsky E, Resar LM. PMID: 19785026.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    102. Application of an expanded multiplex genotyping assay for the simultaneous detection of Hemoglobin Constant Spring and common deletional alpha-thalassemia mutations. Int J Lab Hematol. 2010 Aug 01; 32(4):373-80. Kidd JL, Azimi M, Lubin B, Vichinsky E, Hoppe C. PMID: 19919622.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    103. Iron metabolism and iron chelation in sickle cell disease. Acta Haematol. 2009; 122(2-3):174-83. Walter PB, Harmatz P, Vichinsky E. PMID: 19907155.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    104. Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complications. Am J Hematol. 2009 Nov; 84(11):759-61. Singer ST, Kim HY, Olivieri NF, Kwiatkowski JL, Coates TD, Carson S, Neufeld E, Cunningham MJ, Giardina PJ, Mueller BU, Quinn CT, Fung E, Vichinsky E. PMID: 19787795.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    105. Severe sickle cell disease--pathophysiology and therapy. Biol Blood Marrow Transplant. 2010 Jan; 16(1 Suppl):S64-7. Buchanan G, Vichinsky E, Krishnamurti L, Shenoy S. PMID: 19819341.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    106. Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload. Br J Haematol. 2009 Dec; 147(5):752-9. Taher A, Cappellini MD, Vichinsky E, Galanello R, Piga A, Lawniczek T, Clark J, Habr D, Porter JB. PMID: 19764988.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    107. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood. 2009 Nov 19; 114(21):4632-8. Adamkiewicz TV, Abboud MR, Paley C, Olivieri N, Kirby-Allen M, Vichinsky E, Casella JF, Alvarez OA, Barredo JC, Lee MT, Iyer RV, Kutlar A, McKie KM, McKie V, Odo N, Gee B, Kwiatkowski JL, Woods GM, Coates T, Wang W, Adams RJ. PMID: 19721013.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    108. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol. 2009 Sep; 146(5):546-56. Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Fleisher M, Grady RW, Peterson CM, Giardina PJ. PMID: 19604241.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    109. HLA type and risk of alloimmunization in sickle cell disease. Am J Hematol. 2009 Jul; 84(7):462-4. Hoppe C, Klitz W, Vichinsky E, Styles L. PMID: 19484735.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    110. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer. 2009 Apr; 52(4):486-90. Michlitsch J, Azimi M, Hoppe C, Walters MC, Lubin B, Lorey F, Vichinsky E. PMID: 19061217.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    111. Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res. 2009 Mar; 24(3):543-57. Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Lane J, Schneider R, Fleisher M, Grady RW, Peterson CC, Giardina PJ. PMID: 18505376.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    112. Alpha thalassemia major--new mutations, intrauterine management, and outcomes. Hematology Am Soc Hematol Educ Program. 2009; 35-41. Vichinsky EP. PMID: 20008180.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    113. Pulmonary complications of sickle cell disease. N Engl J Med. 2008 Nov 20; 359(21):2254-65. Gladwin MT, Vichinsky E. PMID: 19020327.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    114. Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells. Am J Hematol. 2008 Nov; 83(11):842-5. Singer ST, Vichinsky EP, Larkin S, Olivieri N, Sweeters N, Kuypers FA. PMID: 18821710.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    115. Hemoglobinopathies. Curr Mol Med. 2008 Nov; 8(7):591. Vichinsky E, Rodgers GP, Rachmilewitz E. PMID: 18991644.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    116. Psychosocial and behavioral outcomes in children with sickle cell disease and their healthy siblings. J Behav Med. 2008 Dec; 31(6):506-16. Gold JI, Mahrer NE, Treadwell M, Weissman L, Vichinsky E. PMID: 18784995.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    117. Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. Haematologica. 2008 Aug; 93(8):1247-51. Harmatz P, Jonas MM, Kwiatkowski JL, Wright EC, Fischer R, Vichinsky E, Giardina PJ, Neufeld EJ, Porter J, Olivieri N. PMID: 18556414.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    118. Detection and assessment of stroke in patients with sickle cell disease: neuropsychological functioning and magnetic resonance imaging. Pediatr Hematol Oncol. 2008 Jun; 25(5):409-21. Gold JI, Johnson CB, Treadwell MJ, Hans N, Vichinsky E. PMID: 18569843.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    119. Oral iron chelators and the treatment of iron overload in pediatric patients with chronic anemia. Pediatrics. 2008 Jun; 121(6):1253-6. Vichinsky E. PMID: 18519495.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    120. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. Transfusion. 2008 Sep; 48(9):1971-80. Fung EB, Harmatz PR, Milet M, Balasa V, Ballas SK, Casella JF, Hilliard L, Kutlar A, McClain KL, Olivieri NF, Porter JB, Vichinsky EP. PMID: 18513257.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    121. An expanded Transactional Stress and Coping Model for siblings of children with sickle cell disease: family functioning and sibling coping, self-efficacy and perceived social support. Child Care Health Dev. 2008 Jul; 34(4):491-502. Gold JI, Treadwell M, Weissman L, Vichinsky E. PMID: 18485027.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    122. Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica. 2008 Jun; 93(6):817-25. Walter PB, Macklin EA, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Coates T, Giardina PJ, Vichinsky E, Olivieri N, Alberti D, Holland J, Harmatz P. PMID: 18469351.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    123. Clinical application of deferasirox: practical patient management. Am J Hematol. 2008 May; 83(5):398-402. Vichinsky E. PMID: 18058997.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    124. Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial. Acta Haematol. 2008; 119(3):133-41. Vichinsky E, Pakbaz Z, Onyekwere O, Porter J, Swerdlow P, Coates T, Lane P, Files B, Mueller BU, Coïc L, Forni GL, Fischer R, Marks P, Rofail D, Abetz L, Baladi JF. PMID: 18408362.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    125. Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia. Bone. 2008 Jul; 43(1):162-168. Fung EB, Harmatz PR, Milet M, Coates TD, Thompson AA, Ranalli M, Mignaca R, Scher C, Giardina P, Robertson S, Neumayr L, Vichinsky EP. PMID: 18430624.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    126. Advances in clinical research in sickle cell disease. Br J Haematol. 2008 May; 141(3):346-56. Hagar W, Vichinsky E. PMID: 18341629.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    127. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatr Blood Cancer. 2008 Feb; 50(2):319-24. Jastaniah W, Harmatz P, Pakbaz Z, Fischer R, Vichinsky E, Walters MC. PMID: 17557314.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    128. Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood. 2008 Apr 15; 111(8):3991-7. Ataga KI, Smith WR, De Castro LM, Swerdlow P, Saunthararajah Y, Castro O, Vichinsky E, Kutlar A, Orringer EP, Rigdon GC, Stocker JW. PMID: 18192510.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    129. Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.]. Hemoglobin. 2008; 32(6):601-7. Porter JB, Taher AT, Cappellini MD, Vichinsky EP. PMID: 19065340.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    130. Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Eur J Haematol. 2008 Feb; 80(2):168-76. Porter J, Galanello R, Saglio G, Neufeld EJ, Vichinsky E, Cappellini MD, Olivieri N, Piga A, Cunningham MJ, Soulières D, Gattermann N, Tchernia G, Maertens J, Giardina P, Kwiatkowski J, Quarta G, Jeng M, Forni GL, Stadler M, Cario H, Debusscher L, Della Porta M, Cazzola M, Greenberg P, Alimena G, Rabault B, Gathmann I, Ford JM, Alberti D, Rose C. PMID: 18028431.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    131. Clinical differences between children and adults with pulmonary hypertension and sickle cell disease. Br J Haematol. 2008 Jan; 140(1):104-12. Hagar RW, Michlitsch JG, Gardner J, Vichinsky EP, Morris CR. PMID: 17916102.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    132. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood. 2008 Jan 01; 111(1):402-10. Morris CR, Suh JH, Hagar W, Larkin S, Bland DA, Steinberg MH, Vichinsky EP, Shigenaga M, Ames B, Kuypers FA, Klings ES. PMID: 17848621.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    133. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer. 2007 Sep; 49(3):329-32. Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E. PMID: 17554789.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    134. Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator. Br J Haematol. 2007 Aug; 138(3):374-81. Harmatz P, Grady RW, Dragsten P, Vichinsky E, Giardina P, Madden J, Jeng M, Miller B, Hanson G, Hedlund B. PMID: 17614825.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    135. Iron homeostasis during transfusional iron overload in beta-thalassemia and sickle cell disease: changes in iron regulatory protein, hepcidin, and ferritin expression. Pediatr Hematol Oncol. 2007 Jun; 24(4):237-43. Jenkins ZA, Hagar W, Bowlus CL, Johansson HE, Harmatz P, Vichinsky EP, Theil EC. PMID: 17613866.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    136. Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Clin Ther. 2007 May; 29(5):909-917. Cappellini MD, Bejaoui M, Agaoglu L, Porter J, Coates T, Jeng M, Lai ME, Mangiagli A, Strauss G, Girot R, Watman N, Ferster A, Loggetto S, Abish S, Cario H, Zoumbos N, Vichinsky E, Opitz H, Ressayre-Djaffer C, Abetz L, Rofail D, Baladi JF. PMID: 17697909.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    137. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Am J Hematol. 2007 Apr; 82(4):255-65. Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, Owen W, Olivieri N, Smith-Whitley K, Darbari D, Wang W, Vichinsky E. PMID: 17094096.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    138. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol. 2007 Feb; 136(3):501-8. Vichinsky E, Onyekwere O, Porter J, Swerdlow P, Eckman J, Lane P, Files B, Hassell K, Kelly P, Wilson F, Bernaudin F, Forni GL, Okpala I, Ressayre-Djaffer C, Alberti D, Holland J, Marks P, Fung E, Fischer R, Mueller BU, Coates T. PMID: 17233848.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCTClinical Trials
    139. Caregiving time in sickle cell disease: psychological effects in maternal caregivers. Pediatr Blood Cancer. 2007 Jan; 48(1):64-71. Moskowitz JT, Butensky E, Harmatz P, Vichinsky E, Heyman MB, Acree M, Wrubel J, Wilson L, Folkman S. PMID: 16622841.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    140. Hemoglobin e syndromes. Hematology Am Soc Hematol Educ Program. 2007; 79-83. Vichinsky E. PMID: 18024613.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    141. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am. 2006 Dec; 88(12):2573-82. Neumayr LD, Aguilar C, Earles AN, Jergesen HE, Haberkern CM, Kammen BF, Nancarrow PA, Padua E, Milet M, Stulberg BN, Williams RA, Orringer EP, Graber N, Robertson SM, Vichinsky EP. PMID: 17142406.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    142. Bone mineral density in children with sickle cell anemia. Pediatr Blood Cancer. 2006 Dec; 47(7):901-6. Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. PMID: 16317761.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    143. Dose-escalation study of ICA-17043 in patients with sickle cell disease. Pharmacotherapy. 2006 Nov; 26(11):1557-64. Ataga KI, Orringer EP, Styles L, Vichinsky EP, Swerdlow P, Davis GA, Desimone PA, Stocker JW. PMID: 17064199.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    144. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol. 2006 Nov; 135(4):574-82. Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, Kalinyak KA, Hudes M, Bhatia S, Vichinsky EP. PMID: 17054676.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    145. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol. 2006 Oct; 135(2):254-63. Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, Harmatz P. PMID: 17010049.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    146. Prevalence of HFE mutations in California newborns. Pediatr Hematol Oncol. 2006 Sep; 23(6):507-16. Hoppe C, Watson RM, Long CM, Lorey F, Robles L, Klitz W, Styles L, Vichinsky E. PMID: 16849282.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    147. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol. 2006 Sep; 81(9):670-5. Singer ST, Kuypers FA, Styles L, Vichinsky EP, Foote D, Rosenfeld H. PMID: 16795058.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    148. Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function. Br J Haematol. 2006 May; 133(4):433-5. Hagar RW, Morris CR, Vichinsky EP. PMID: 16643452.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    149. Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait. J Natl Med Assoc. 2006 May; 98(5):704-10. Treadwell MJ, McClough L, Vichinsky E. PMID: 16749645.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    150. Prevalence of fractures among the Thalassemia syndromes in North America. Bone. 2006 Apr; 38(4):571-5. Vogiatzi MG, Macklin EA, Fung EB, Vichinsky E, Olivieri N, Kwiatkowski J, Cohen A, Neufeld E, Giardina PJ. PMID: 16298178.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    151. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics. 2005 Dec; 116(6):e818-25. Vichinsky EP, MacKlin EA, Waye JS, Lorey F, Olivieri NF. PMID: 16291734.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    152. Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome. Br J Haematol. 2005 Nov; 131(3):378-88. Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP. PMID: 16225658.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    153. Bone and joint disease in sickle cell disease. Hematol Oncol Clin North Am. 2005 Oct; 19(5):929-41, viii. Aguilar C, Vichinsky E, Neumayr L. PMID: 16214653.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    154. Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Am J Hematol. 2005 Sep; 80(1):70-4. Vichinsky E, Butensky E, Fung E, Hudes M, Theil E, Ferrell L, Williams R, Louie L, Lee PD, Harmatz P. PMID: 16138345.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    155. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005 Jul 06; 294(1):81-90. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM, Gladwin MT. PMID: 15998894.
      View in: PubMed   Mentions: 210     Fields:    Translation:Humans
    156. Clinical evaluation of avascular necrosis in patients with sickle cell disease: Children's Hospital Oakland Hip Evaluation Scale--a modification of the Harris Hip Score. Arch Phys Med Rehabil. 2005 Jul; 86(7):1369-75. Aguilar CM, Neumayr LD, Eggleston BE, Earles AN, Robertson SM, Jergesen HE, Stulberg BN, Vichinsky EP. PMID: 16003666.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    157. Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatr Blood Cancer. 2005 May; 44(5):500-7. Treadwell MJ, Law AW, Sung J, Hackney-Stephens E, Quirolo K, Murray E, Glendenning GA, Vichinsky E. PMID: 15602707.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    158. Treatment of hepatitis C virus infection in thalassemia. Ann N Y Acad Sci. 2005; 1054:290-9. Butensky E, Pakbaz Z, Foote D, Walters MC, Vichinsky EP, Harmatz P. PMID: 16339677.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    159. Measuring chromosome breaks in patients with thalassemia. Ann N Y Acad Sci. 2005; 1054:439-44. Offer T, Bhagat A, Lal A, Atamna W, Singer ST, Vichinsky EP, Kuypers FA, Ames BN. PMID: 16339694.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    160. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann N Y Acad Sci. 2005; 1054:457-61. Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, Singer T, Vichinsky EP. PMID: 16339697.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    161. Utility of Holter electrocardiogram in iron-overloaded hemoglobinopathies. Ann N Y Acad Sci. 2005; 1054:476-80. Qureshi N, Avasarala K, Foote D, Vichinsky EP. PMID: 16339701.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    162. Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci. 2005; 1054:481-5. Morris CR, Kuypers FA, Kato GJ, Lavrisha L, Larkin S, Singer T, Vichinsky EP. PMID: 16339702.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    163. Outcomes of preimplantation genetic diagnosis therapy in treatment of beta-thalassemia: A retrospective analysis. Ann N Y Acad Sci. 2005; 1054:500-3. Qureshi N, Foote D, Walters MC, Singer ST, Quirolo K, Vichinsky EP. PMID: 16339706.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    164. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol. 2005 Jan; 123(1):146-52. Butensky E, Fischer R, Hudes M, Schumacher L, Williams R, Moyer TP, Vichinsky E, Harmatz P. PMID: 15762291.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    165. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005; 1054:18-24. Vichinsky EP. PMID: 16339647.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansPHPublic Health
    166. Hemoglobin E-beta-thalassemia: Progress report from the International Study Group. Ann N Y Acad Sci. 2005; 1054:33-9. Premawardhena A, De Silver S, Arambepola M, Olivieri NF, Vichinsky EP, Merson L, Muraco G, Allen A, Fisher C, Peto T, Weatherall DJ. PMID: 16339649.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    167. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. Ann N Y Acad Sci. 2005; 1054:250-6. Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP. PMID: 16339672.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    168. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia. Ann N Y Acad Sci. 2005; 1054:486-91. Pakbaz Z, Fischer R, Treadwell M, Yamashita R, Fung EB, Calvelli L, Quirolo K, Foote D, Harmatz P, Vichinsky EP. PMID: 16339703.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    169. Hematologic problems in immigrants from Southeast Asia. Hematol Oncol Clin North Am. 2004 Dec; 18(6):1405-22, x. Jeng MR, Vichinsky E. PMID: 15511622.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    170. The new SQUID biosusceptometer at Oakland: first year of experience. Neurol Clin Neurophysiol. 2004 Nov 30; 2004:5. Fung EB, Fischer R, Pakbaz Z, Fagaly RL, Vichinsky E, Starr TN, Ewing T, Paulson DN, Hassenzahl WV, Harmatz P. PMID: 16012600.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    171. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatr Radiol. 2005 Jan; 35(1):66-72. Jones A, Granger S, Brambilla D, Gallagher D, Vichinsky E, Woods G, Berman B, Roach S, Nichols F, Adams RJ. PMID: 15517239.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    172. Thalassemia in Sri Lanka: a progress report. Hum Mol Genet. 2004 Oct 01; 13 Spec No 2:R203-6. Premawardhena A, De Silva S, Arambepola M, Olivieri N, Merson L, Muraco J, Allen A, Fisher C, Peto T, Vichinsky E, Weatherall D. PMID: 15358726.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    173. The role of fetal hemoglobin-enhancing agents in thalassemia. Semin Hematol. 2004 Oct; 41(4 Suppl 6):17-22. Lal A, Vichinsky E. PMID: 15534853.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    174. Pulmonary hypertension in sickle cell disease. N Engl J Med. 2004 Feb 26; 350(9):857-9. Vichinsky EP. PMID: 14985481.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    175. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94. Adams RJ, Brambilla DJ, Granger S, Gallagher D, Vichinsky E, Abboud MR, Pegelow CH, Woods G, Rohde EM, Nichols FT, Jones A, Luden JP, Bowman L, Hagner S, Morales KH, Roach ES. PMID: 14751925.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    176. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004; 14-34. Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. PMID: 15561674.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    177. Managing sickle cell disease. BMJ. 2003 Nov 15; 327(7424):1151-5. Claster S, Vichinsky EP. PMID: 14615343.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    178. Gene interactions and stroke risk in children with sickle cell anemia. Blood. 2004 Mar 15; 103(6):2391-6. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L. PMID: 14615367.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    179. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr. 2003 Oct; 143(4):438-44. Adamkiewicz TV, Sarnaik S, Buchanan GR, Iyer RV, Miller ST, Pegelow CH, Rogers ZR, Vichinsky E, Elliott J, Facklam RR, O'Brien KL, Schwartz B, Van Beneden CA, Cannon MJ, Eckman JR, Keyserling H, Sullivan K, Wong WY, Wang WC. PMID: 14571216.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    180. Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease. J Pediatr Hematol Oncol. 2003 Aug; 25(8):629-34. Morris CR, Vichinsky EP, van Warmerdam J, Machado L, Kepka-Lenhart D, Morris SM, Kuypers FA. PMID: 12902916.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    181. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics. 2003 Jul; 112(1 Pt 1):87-95. Neumayr L, Lennette E, Kelly D, Earles A, Embury S, Groncy P, Grossi M, Grover R, McMahon L, Swerdlow P, Waldron P, Vichinsky E. PMID: 12837872.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    182. Deferiprone and hepatic fibrosis. Blood. 2003 Jun 15; 101(12):5089-90; author reply 5090-1. Brittenham GM, Nathan DG, Olivieri NF, Porter JB, Pippard M, Vichinsky EP, Weatherall DJ. PMID: 12788794.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    183. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003 Apr 02; 289(13):1645-51. Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M. PMID: 12672732.
      View in: PubMed   Mentions: 195     Fields:    Translation:HumansCTClinical Trials
    184. Liver ferritin subunit ratios in neonatal hemochromatosis. Pediatr Hematol Oncol. 2003 Apr-May; 20(3):229-35. Hagar W, Vichinsky EP, Theil EC. PMID: 12637219.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    185. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med. 2003 Jul 01; 168(1):63-9. Morris CR, Morris SM, Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, Vichinsky EP. PMID: 12626350.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCTClinical Trials
    186. Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease. J Pediatr Hematol Oncol. 2003 Jan; 25(1):46-55. Dean D, Neumayr L, Kelly DM, Ballas SK, Kleman K, Robertson S, Iyer RV, Ware RE, Koshy M, Rackoff WR, Pegelow CH, Waldron P, Benjamin L, Vichinsky E. PMID: 12544773.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    187. Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood. 2003 Apr 01; 101(7):2865-9. Hoppe C, Klitz W, Noble J, Vigil L, Vichinsky E, Styles L. PMID: 12517810.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    188. Pancytopenia induced by hypothermia. J Pediatr Hematol Oncol. 2002 Nov; 24(8):681-4. Lo L, Singer ST, Vichinsky E. PMID: 12439045.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    189. Diseases of iron metabolism. Pediatr Clin North Am. 2002 Oct; 49(5):893-909. Hagar W, Theil EC, Vichinsky EP. PMID: 12430618.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    190. New therapies in sickle cell disease. Lancet. 2002 Aug 24; 360(9333):629-31. Vichinsky E. PMID: 12241949.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    191. Bioelectrical impedance analysis of the body composition of children and adolescents with sickle cell disease. J Pediatr. 2002 Jun; 140(6):681-7. VanderJagt DJ, Harmatz P, Scott-Emuakpor AB, Vichinsky E, Glew RH. PMID: 12072870.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    192. Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol. 2002 May; 24(4):284-90. Files B, Brambilla D, Kutlar A, Miller S, Vichinsky E, Wang W, Granger S, Adams RJ. PMID: 11972097.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    193. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002 Apr 15; 99(8):3014-8. Pegelow CH, Macklin EA, Moser FG, Wang WC, Bello JA, Miller ST, Vichinsky EP, DeBaun MR, Guarini L, Zimmerman RA, Younkin DP, Gallagher DM, Kinney TR. PMID: 11929794.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    194. Central venous catheter complications in sickle cell disease. Am J Hematol. 2002 Feb; 69(2):103-8. Jeng MR, Feusner J, Skibola C, Vichinsky E. PMID: 11835345.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    195. Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool. J Pain Symptom Manage. 2002 Feb; 23(2):114-20. Franck LS, Treadwell M, Jacob E, Vichinsky E. PMID: 11844631.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    196. Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study. J Pediatr. 2002 Feb; 140(2):225-9. Wang WC, Helms RW, Lynn HS, Redding-Lallinger R, Gee BE, Ohene-Frempong K, Smith-Whitley K, Waclawiw MA, Vichinsky EP, Styles LA, Ware RE, Kinney TR. PMID: 11865275.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    197. Using quality improvement strategies to enhance pediatric pain assessment. Int J Qual Health Care. 2002 Feb; 14(1):39-47. Treadwell MJ, Franck LS, Vichinsky E. PMID: 11871628.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    198. Novel therapeutic approaches in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2002; 10-34. Walters MC, Nienhuis AW, Vichinsky E. PMID: 12446417.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    199. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol. 2001 Dec; 58(12):2017-21. Pegelow CH, Wang W, Granger S, Hsu LL, Vichinsky E, Moser FG, Bello J, Zimmerman RA, Adams RJ, Brambilla D. PMID: 11735775.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    200. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001 Sep; 41(9):1086-92. Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ. PMID: 11552063.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCellsCTClinical Trials
    201. A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia. Br J Haematol. 2001 Sep; 114(3):718-20. Hoppe C, Cheng S, Grow M, Silbergleit A, Klitz W, Trachtenberg E, Erlich H, Vichinsky E, Styles L. PMID: 11553004.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    202. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001 Sep; 139(3):385-90. Miller ST, Macklin EA, Pegelow CH, Kinney TR, Sleeper LA, Bello JA, DeWitt LD, Gallagher DM, Guarini L, Moser FG, Ohene-Frempong K, Sanchez N, Vichinsky EP, Wang WC, Wethers DL, Younkin DP, Zimmerman RA, DeBaun MR. PMID: 11562618.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    203. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001 Sep; 139(3):391-7. Wang W, Enos L, Gallagher D, Thompson R, Guarini L, Vichinsky E, Wright E, Zimmerman R, Armstrong FD. PMID: 11562619.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    204. Correlation of abnormal intracranial vessel velocity, measured by transcranial Doppler ultrasonography, with abnormal conjunctival vessel velocity, measured by computer-assisted intravital microscopy, in sickle cell disease. Blood. 2001 Jun 01; 97(11):3401-4. Cheung AT, Harmatz P, Wun T, Chen PC, Larkin EC, Adams RJ, Vichinsky EP. PMID: 11369629.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    205. Transfusion therapy: a coming-of-age treatment for patients with sickle cell disease. J Pediatr Hematol Oncol. 2001 May; 23(4):197-202. Reed W, Vichinsky EP. PMID: 11846294.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    206. Nesidioblastosis in sickle cell disease. Pediatr Pathol Mol Med. 2001 Mar-Apr; 20(2):155-65. Culberson DE, Manci EA, Shah AK, Haynes J, Ballas SK, Pegelow C, Vichinsky E. PMID: 12673839.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    207. Stem cell transplantation for sickle cell disease: can we reduce the toxicity? Pediatr Pathol Mol Med. 2001 Jan-Feb; 20(1):73-86. Fixler J, Vichinsky E, Walters MC. PMID: 12673845.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    208. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 2001; 7(12):665-73. Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR, Roberts IA, Yeager AM, Hsu L, Adamkiewicz T, Kurtzberg J, Vichinsky E, Storer B, Storb R, Sullivan KM. PMID: 11787529.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCTClinical Trials
    209. Universal newborn screening for Hb H disease in California. Genet Test. 2001; 5(2):93-100. Lorey F, Cunningham G, Vichinsky EP, Lubin BH, Witkowska HE, Matsunaga A, Azimi M, Sherwin J, Eastman J, Farina F, Waye JS, Chui DH. PMID: 11551109.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    210. Current issues with blood transfusions in sickle cell disease. Semin Hematol. 2001 Jan; 38(1 Suppl 1):14-22. Vichinsky EP. PMID: 11206956.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    211. Consensus document for transfusion-related iron overload. Semin Hematol. 2001 Jan; 38(1 Suppl 1):2-4. Vichinsky E. PMID: 11206957.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    212. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood. 2000 Nov 15; 96(10):3369-73. Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. PMID: 11071629.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    213. Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood. 2000 Nov 01; 96(9):3276-8. Styles LA, Aarsman AJ, Vichinsky EP, Kuypers FA. PMID: 11050014.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    214. Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. Br J Haematol. 2000 Nov; 111(2):498-500. Morris CR, Kuypers FA, Larkin S, Sweeters N, Simon J, Vichinsky EP, Styles LA. PMID: 11122090.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    215. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol. 2000 Nov-Dec; 22(6):515-20. Morris CR, Kuypers FA, Larkin S, Vichinsky EP, Styles LA. PMID: 11132219.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    216. Changing outcome of homozygous alpha-thalassemia: cautious optimism. J Pediatr Hematol Oncol. 2000 Nov-Dec; 22(6):539-42. Singer ST, Styles L, Bojanowski J, Quirolo K, Foote D, Vichinsky EP. PMID: 11132224.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    217. Outreach strategies for Southeast Asian communities: experience, practice, and suggestions for approaching Southeast Asian immigrant and refugee communities to provide thalassemia education and trait testing. J Pediatr Hematol Oncol. 2000 Nov-Dec; 22(6):588-92. Choy J, Foote D, Bojanowski J, Yamashita R, Vichinsky E. PMID: 11132235.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    218. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):335-9. Wang WC, Gallagher DM, Pegelow CH, Wright EC, Vichinsky EP, Abboud MR, Moser FG, Adams RJ. PMID: 10959904.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    219. Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):330-4. Hoppe C, Vichinsky E, Quirolo K, van Warmerdam J, Allen K, Styles L. PMID: 10959903.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    220. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood. 2000 Jul 01; 96(1):76-9. Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, Golden D, Neumayr L, Vichinsky E. PMID: 10891433.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    221. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000 Jun 22; 342(25):1855-65. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA. PMID: 10861320.
      View in: PubMed   Mentions: 179     Fields:    Translation:Humans
    222. Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. Blood. 2000 Jun 01; 95(11):3562-7. Styles LA, Hoppe C, Klitz W, Vichinsky E, Lubin B, Trachtenberg E. PMID: 10828044.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    223. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood. 2000 Mar 15; 95(6):1918-24. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE, Buchanan GE, Rogers ZR, Dinndorf P, Davies SC, Roberts IA, Dickerhoff R, Yeager AM, Hsu L, Kurtzberg J, Ohene-Frempong K, Bunin N, Bernaudin F, Wong WY, Scott JP, Margolis D, Vichinsky E, Wall DA, Wayne AS, Pegelow C, Redding-Lallinger R, Wiley J, Klemperer M, Mentzer WC, Smith FO, Sullivan KM. PMID: 10706855.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    224. Sickle-cell disease not identified by newborn screening because of prior transfusion. J Pediatr. 2000 Feb; 136(2):248-50. Reed W, Lane PA, Lorey F, Bojanowski J, Glass M, Louie RR, Lubin BH, Vichinsky EP. PMID: 10657834.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    225. Major changes in sickle cell disease. Adv Pediatr. 2000; 47:249-72. Hagar RW, Vichinsky EP. PMID: 10959446.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    226. Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia. Am J Hematol. 1999 Dec; 62(4):221-7. Hoppe C, Vichinsky E, Lewis B, Foote D, Styles L. PMID: 10589077.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    227. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group. Am J Hematol. 1999 Nov; 62(3):129-38. Vichinsky EP, Neumayr LD, Haberkern C, Earles AN, Eckman J, Koshy M, Black DM. PMID: 10539878.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    228. Transfusion practice for patients with sickle cell disease. Curr Opin Hematol. 1999 Nov; 6(6):432-6. Reed WF, Vichinsky EP. PMID: 10546799.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    229. Bone disease in beta-thalassaemia. Lancet. 1999 Sep 11; 354(9182):881-2. Singer ST, Vichinsky EP. PMID: 10489942.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    230. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood. 1999 Sep 01; 94(5):1550-4. Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, Redding-Lallinger R, Gee B, Platt OS, Ware RE. PMID: 10477679.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCTClinical Trials
    231. Effects of red blood cell transfusion on resting energy expenditure in adolescents with sickle cell anemia. J Pediatr Gastroenterol Nutr. 1999 Aug; 29(2):127-31. Harmatz P, Heyman MB, Cunningham J, Lee PD, Styles L, Quirolo K, Kopp-Hoolihan L, Ghiron J, Hintz RL, Vichinsky E. PMID: 10435647.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    232. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough? Ann Emerg Med. 1999 Jul; 34(1):64-9. Morris C, Vichinsky E, Styles L. PMID: 10381996.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    233. Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. Am J Hematol. 1999 Apr; 60(4):268-72. Reed W, Jagust W, Al-Mateen M, Vichinsky E. PMID: 10203099.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    234. Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. Preoperative Transfusion in Sickle Cell Disease Study Group. J Pediatr Hematol Oncol. 1999 Mar-Apr; 21(2):129-35. Waldron P, Pegelow C, Neumayr L, Haberkern C, Earles A, Wesman R, Vichinsky E. PMID: 10206459.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    235. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics. 1999 Mar; 103(3):640-5. Kinney TR, Sleeper LA, Wang WC, Zimmerman RA, Pegelow CH, Ohene-Frempong K, Wethers DL, Bello JA, Vichinsky EP, Moser FG, Gallagher DM, DeBaun MR, Platt OS, Miller ST. PMID: 10049969.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    236. Deferoxamine treatment during pregnancy: is it harmful? Am J Hematol. 1999 Jan; 60(1):24-6. Singer ST, Vichinsky EP. PMID: 9883802.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    237. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload. J Clin Apher. 1999; 14(3):122-5. Singer ST, Quirolo K, Nishi K, Hackney-Stephens E, Evans C, Vichinsky EP. PMID: 10540366.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    238. Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction. Transfusion. 1998 Nov-Dec; 38(11-12):1041-5. Reed W, Lee TH, Vichinsky EP, Lubin BH, Busch MP. PMID: 9838935.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    239. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 02; 339(1):5-11. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D. PMID: 9647873.
      View in: PubMed   Mentions: 293     Fields:    Translation:HumansCTClinical Trials
    240. Outreach strategies for Asian Pacific Island (API) communities. Ann N Y Acad Sci. 1998 Jun 30; 850:514-5. Choy J, Yamashita RC, Foote D, Heer N, Vichinsky EP. PMID: 9705740.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    241. The hemoglobin E syndromes. Ann N Y Acad Sci. 1998 Jun 30; 850:334-43. Rees DC, Styles L, Vichinsky EP, Clegg JB, Weatherall DJ. PMID: 9668555.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    242. The morbidity of bone disease in thalassemia. Ann N Y Acad Sci. 1998 Jun 30; 850:344-8. Vichinsky EP. PMID: 9668556.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    243. Preliminary report: hydroxyurea produces significant clinical response in thalassemia intermedia. Ann N Y Acad Sci. 1998 Jun 30; 850:461-2. Styles L, Lewis B, Foote D, Cuda L, Vichinsky EP. PMID: 9668584.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    244. Bone marrow transplant in thalassemia. A role for radiation? Ann N Y Acad Sci. 1998 Jun 30; 850:503-5. Lee YS, Kristovich KM, Ducore JM, Vichinsky E, Crouse VL, Glader BE, Amylon MD. PMID: 9668596.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    245. The social impact of migration on disease. Cooley's anemia, thalassemia, and new Asian immigrants. Ann N Y Acad Sci. 1998 Jun 30; 850:509-11. Heer N, Choy J, Vichinsky EP. PMID: 9668597.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    246. Approaches to working with adult thalassemia patients in pediatric settings. Ann N Y Acad Sci. 1998 Jun 30; 850:516-7. Weissman L, Treadwell M, Foote D, Heer N, Vichinsky EP. PMID: 9668599.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    247. Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin. J Pediatr. 1998 May; 132(5):871-3. Fridge JL, Vichinsky EP. PMID: 9602203.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    248. Acute chest syndrome and sickle cell disease. Curr Opin Hematol. 1998 Mar; 5(2):89-92. Golden C, Styles L, Vichinsky E. PMID: 9570700.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    249. The natural history of sickle cell disease. Curr Opin Pediatr. 1998 Feb; 10(1):49-52. Hoppe C, Styles L, Vichinsky E. PMID: 9529638.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    250. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb; 19(1):110-29. Adams RJ, McKie VC, Brambilla D, Carl E, Gallagher D, Nichols FT, Roach S, Abboud M, Berman B, Driscoll C, Files B, Hsu L, Hurlet A, Miller S, Olivieri N, Pegelow C, Scher C, Vichinsky E, Wang W, Woods G, Kutlar A, Wright E, Hagner S, Tighe F, Waclawiw MA. PMID: 9492971.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCTClinical Trials
    251. Surgery in patients with hemoglobin SC disease. Preoperative Transfusion in Sickle Cell Disease Study Group. Am J Hematol. 1998 Feb; 57(2):101-8. Neumayr L, Koshy M, Haberkern C, Earles AN, Bellevue R, Hassell K, Miller S, Black D, Vichinsky E. PMID: 9462540.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    252. New considerations in the treatment of sickle cell disease. Annu Rev Med. 1998; 49:461-74. Reed W, Vichinsky EP. PMID: 9509275.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    253. Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy. J Pediatr Hematol Oncol. 1998 Jan-Feb; 20(1):26-31. Olivieri NF, Vichinsky EP. PMID: 9482409.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    254. Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study II. J Pediatr Hematol Oncol. 1997 Jul-Aug; 19(4):327-33. Woods GM, Jorgensen JH, Waclawiw MA, Reid C, Wang W, Pegelow CH, Rogers ZR, Iyer RV, Holbrook CT, Kinney TR, Vichinsky E, DeBaun MR, Grossman NJ, Thomas MD, Falletta JM. PMID: 9256832.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    255. Hydroxyurea in children: present and future. Semin Hematol. 1997 Jul; 34(3 Suppl 3):22-9. Vichinsky EP. PMID: 9317198.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    256. Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. J Pediatr. 1997 May; 130(5):695-703. Kelly P, Kurtzberg J, Vichinsky E, Lubin B. PMID: 9152276.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    257. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood. 1997 Apr 01; 89(7):2554-9. Styles LA, Lubin B, Vichinsky E, Lawrence S, Hua M, Test S, Kuypers F. PMID: 9116302.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    258. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997 Mar 01; 89(5):1533-42. Haberkern CM, Neumayr LD, Orringer EP, Earles AN, Robertson SM, Black D, Abboud MR, Koshy M, Idowu O, Vichinsky EP. PMID: 9057634.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    259. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood. 1997 Mar 01; 89(5):1787-92. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. PMID: 9057664.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    260. New therapies and approaches to transfusion in sickle cell disease in children. Curr Opin Pediatr. 1997 Feb; 9(1):41-5. Styles LA, Vichinsky EP. PMID: 9088754.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    261. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med. 1997 Feb; 102(2):171-7. Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, Vichinsky E. PMID: 9217567.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    262. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr. 1996 Dec; 129(6):828-35. Bjornson AB, Falletta JM, Verter JI, Buchanan GR, Miller ST, Pegelow CH, Iyer RV, Johnstone HS, DeBaun MR, Wethers DL, Wang WC, Woods GM, Holbrook CT, Becton DL, Kinney TR, Reaman GH, Kalinyak K, Grossman NJ, Vichinsky E, Reid CD. PMID: 8969724.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    263. Pulmonary complications. Hematol Oncol Clin North Am. 1996 Dec; 10(6):1275-87. Vichinsky E, Styles L. PMID: 8956016.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    264. First report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: splenic regeneration. Blood. 1996 Sep 15; 88(6):1951-3. Claster S, Vichinsky E. PMID: 8822912.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    265. Core decompression in avascular necrosis of the hip in sickle-cell disease. Am J Hematol. 1996 Jun; 52(2):103-7. Styles LA, Vichinsky EP. PMID: 8638629.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    266. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol. 1996 May; 17(5):965-72. Moser FG, Miller ST, Bello JA, Pegelow CH, Zimmerman RA, Wang WC, Ohene-Frempong K, Schwartz A, Vichinsky EP, Gallagher D, Kinney TR. PMID: 8733975.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    267. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 1996 May; 2(2):100-4. Walters MC, Patience M, Leisenring W, Eckman JR, Buchanan GR, Rogers ZR, Olivieri NE, Vichinsky E, Davies SC, Mentzer WC, Powars D, Scott JP, Bernaudin F, Ohene-Frempong K, Darbyshire PJ, Wayne A, Roberts IA, Dinndorf P, Brandalise S, Sanders JE, Matthews DC, Appelbaum FR, Storb R, Sullivan KM. PMID: 9118298.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    268. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood. 1996 Mar 15; 87(6):2573-8. Styles LA, Schalkwijk CG, Aarsman AJ, Vichinsky EP, Lubin BH, Kuypers FA. PMID: 8630425.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    269. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program. J Pediatr Hematol Oncol. 1996 Feb; 18(1):36-41. Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B. PMID: 8556368.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    270. Ototoxicity in hemoglobinopathy patients chelated with desferrioxamine. J Pediatr Hematol Oncol. 1996 Feb; 18(1):42-5. Styles LA, Vichinsky EP. PMID: 8556369.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    271. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood. 1995 Nov 15; 86(10):3676-84. Koshy M, Weiner SJ, Miller ST, Sleeper LA, Vichinsky E, Brown AK, Khakoo Y, Kinney TR. PMID: 7579333.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    272. Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II. J Pediatr. 1995 Nov; 127(5):685-90. Falletta JM, Woods GM, Verter JI, Buchanan GR, Pegelow CH, Iyer RV, Miller ST, Holbrook CT, Kinney TR, Vichinsky E. PMID: 7472817.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCellsCTClinical Trials
    273. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995 Jul 27; 333(4):206-13. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M, Ohene-Frempong K, Iyer RV. PMID: 7791837.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    274. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood. 1995 Jul 15; 86(2):776-83. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, Pegelow CH, Vichinsky E. PMID: 7606007.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    275. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9. Pegelow CH, Adams RJ, McKie V, Abboud M, Berman B, Miller ST, Olivieri N, Vichinsky E, Wang W, Brambilla D. PMID: 7776091.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    276. Liver transplantation in a child with sickle cell anemia. Transplantation. 1995 May 27; 59(10):1490-2. Lang T, Berquist WE, So SK, Cox KL, Rich EJ, Vichinsky E, Concepcion W, Esquivel CO. PMID: 7770941.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    277. Chronic pulmonary disorders in sickle cell disease: findings at thin-section CT. Radiology. 1994 Dec; 193(3):807-11. Aquino SL, Gamsu G, Fahy JV, Claster S, Embury SH, Mentzer WC, Vichinsky EP. PMID: 7972829.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    278. Effects of a long-term transfusion regimen on sickle cell-related illnesses. J Pediatr. 1994 Dec; 125(6 Pt 1):909-11. Styles LA, Vichinsky E. PMID: 7996363.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    279. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood. 1994 Jun 01; 83(11):3107-12. Vichinsky E, Williams R, Das M, Earles AN, Lewis N, Adler A, McQuitty J. PMID: 8193347.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    280. New advances in the pathophysiology and management of sickle cell disease. Curr Opin Hematol. 1994 Mar; 1(2):125-35. Shafer FE, Vichinsky E. PMID: 9371271.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    281. A cautionary note regarding hydroxyurea in sickle cell disease. Blood. 1994 Feb 15; 83(4):1124-8. Vichinsky EP, Lubin BH. PMID: 7509209.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    282. Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):27-9. Mentzer WC, Heller S, Pearle PR, Hackney E, Vichinsky E. PMID: 8311169.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    283. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):67-71. Perrine SP, Olivieri NF, Faller DV, Vichinsky EP, Dover GJ, Ginder GD. PMID: 7508690.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    284. Universal screening for hemoglobinopathies using high-performance liquid chromatography: clinical results of 2.2 million screens. Eur J Hum Genet. 1994; 2(4):262-71. Lorey F, Cunningham G, Shafer F, Lubin B, Vichinsky E. PMID: 7704556.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    285. Detection of Hb E/beta-thalassemia versus homozygous EE using high-performance liquid chromatography results from newborns. Biochem Med Metab Biol. 1993 Feb; 49(1):67-73. Lorey FW, Cunningham GC, Vichinsky E, Lubin B, Shafer F, Eastman J. PMID: 7679916.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    286. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med. 1993 Jan 14; 328(2):81-6. Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE, Cai SP, Vichinsky EP, Olivieri NF. PMID: 7677966.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCTClinical Trials
    287. F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study. Blood. 1993 Jan 01; 81(1):9-14. Nagel RL, Vichinsky E, Shah M, Johnson R, Spadacino E, Fabry ME, Mangahas L, Abel R, Stamatoyannopoulos G. PMID: 8417806.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    288. Differentiation of homozygous hemoglobin E from compound heterozygous hemoglobin E-beta O-thalassemia by hemoglobin E mutation analysis. J Pediatr. 1992 May; 120(5):775-9. Johnson JP, Vichinsky E, Hurst D, Camber A, Lubin B, Louie E. PMID: 1374466.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    289. Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-Chori. N Engl J Med. 1991 Oct 17; 325(16):1150-4. Witkowska HE, Lubin BH, Beuzard Y, Baruchel S, Esseltine DW, Vichinsky EP, Kleman KM, Bardakdjian-Michau J, Pinkoski L, Cahn S. PMID: 1891024.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    290. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991 Jul 04; 325(1):11-6. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR. PMID: 1710777.
      View in: PubMed   Mentions: 355     Fields:    Translation:Humans
    291. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol. 1991 Jul; 28(3):220-6. Vichinsky EP. PMID: 1887248.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    292. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990 Jun 07; 322(23):1617-21. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. PMID: 2342522.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    293. Vitamin C deficiency in patients with sickle cell anemia. Am J Pediatr Hematol Oncol. 1990; 12(3):262-7. Chiu D, Vichinsky E, Ho SL, Liu T, Lubin BH. PMID: 2240472.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    294. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia. Blood. 1989 Jul; 74(1):454-9. Perrine SP, Miller BA, Faller DV, Cohen RA, Vichinsky EP, Hurst D, Lubin BH, Papayannopoulou T. PMID: 2473801.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    295. Experience with newborn screening using isoelectric focusing. Pediatrics. 1989 May; 83(5 Pt 2):852-4. Kleman KM, Vichinsky E, Lubin BH. PMID: 2717314.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    296. Elevated fasting breath hydrogen and abnormal hydrogen breath tests in children with sickle cell disease: a preliminary report. Am J Clin Nutr. 1989 Apr; 49(4):654-7. Heyman MB, Lande W, Vichinsky E, Mentzer W. PMID: 2929487.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    297. Butyrate analogues modulate globin gene expression in human and ovine erythroid cells. Prog Clin Biol Res. 1989; 316B:341-50. Perrine SP, Miller BA, Papayannopoulou T, Faller DV, Rudolph AM, Vichinsky E, Hurst D, Kan YW. PMID: 2616579.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    298. Hematopoietic hormones: from cloning to clinic. Am J Pediatr Hematol Oncol. 1989; 11(3):268-75. Perrine SP, Vichinsky E, Faller DV. PMID: 2675659.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    299. Newborn screening for sickle cell disease: effect on mortality. Pediatrics. 1988 Jun; 81(6):749-55. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. PMID: 3368274.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansPHPublic Health
    300. Contraceptive use in the chronically ill adolescent female. J Adolesc Health Care. 1988 Jan; 9(1):87. Vichinsky E, McDonald C. PMID: 3335479.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    301. Suggested guidelines for the treatment of children with sickle cell anemia. Hematol Oncol Clin North Am. 1987 Sep; 1(3):483-501. Vichinsky E, Lubin BH. PMID: 3329183.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    302. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986 Jun 19; 314(25):1593-9. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS. PMID: 3086721.
      View in: PubMed   Mentions: 157     Fields:    Translation:HumansCTClinical Trials
    303. Growth retardation in sickle-cell disease treated by nutritional support. Lancet. 1985 Apr 20; 1(8434):903-6. Heyman MB, Vichinsky E, Katz R, Gaffield B, Hurst D, Castillo R, Chiu D, Kleman K, Ammann AJ, Thaler MM. PMID: 2858749.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    304. Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia. J Pediatr. 1984 Aug; 105(2):261-3. Weintrub PS, Schiffman G, Addiego JE, Matthay KK, Vichinsky E, Johnson R, Lubin B, Mentzer WC, Ammann AJ. PMID: 6747758.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    305. Inadequate erythroid response to hypoxia in cystic fibrosis. J Pediatr. 1984 Jul; 105(1):15-21. Vichinsky EP, Pennathur-Das R, Nickerson B, Minor M, Kleman K, Higashino S, Lubin B. PMID: 6737132.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    306. Evidence for the presence of CFU-E with increased in vitro sensitivity to erythropoietin in sickle cell anemia. Blood. 1984 May; 63(5):1168-71. Pennathur-Das R, Alpen E, Vichinsky E, Garcia J, Lubin B. PMID: 6713094.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    307. Evidence for a heterogeneous response to erythropoietin in the CFUE pool of human bone marrow. Exp Hematol. 1984 Jan; 12(1):31-7. Pennathur-Das R, Alpen E, Vichinsky E, Lubin B. PMID: 6583068.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    308. Iron deficiency in health and disease. Adv Pediatr. 1983; 30:281-320. Reeves JD, Vichinsky E, Addiego J, Lubin BH. PMID: 6369941.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    309. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. N Engl J Med. 1982 Feb 04; 306(5):270-4. Embury SH, Dozy AM, Miller J, Davis JR, Kleman KM, Preisler H, Vichinsky E, Lande WN, Lubin BH, Kan YW, Mentzer WC. PMID: 6172710.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    310. Peroxidation, vitamin E, and sickle-cell anemia. Ann N Y Acad Sci. 1982; 393:323-35. Chiu D, Vichinsky E, Yee M, Kleman K, Lubin B. PMID: 6959561.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    311. Multidisciplinary approach to pain management in sickle cell disease. Am J Pediatr Hematol Oncol. 1982; 4(3):328-33. Vichinsky EP, Johnson R, Lubin BH. PMID: 6128939.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    312. The diagnosis of iron deficiency anemia in sickle cell disease. Blood. 1981 Nov; 58(5):963-8. Vichinsky E, Kleman K, Embury S, Lubin B. PMID: 7296005.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    313. Current treatment of sickle cell disease. Curr Probl Pediatr. 1980 Oct; 10(12):1-64. Davis JR, Vichinsky EP, Lubin BH. PMID: 7428420.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    314. Sickle cell anemia and related hemoglobinopathies. Pediatr Clin North Am. 1980 May; 27(2):429-47. Vichinsky EP, Lubin BH. PMID: 6155657.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    315. Unstable hemoglobins, hemoglobins with altered oxygen affinity, and m-hemoglobins. Pediatr Clin North Am. 1980 May; 27(2):421-8. Vichinsky EP, Lubin BH. PMID: 7383714.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    316. Fetal Hb production during acute erythroid expansion. I. Observations in patients with transient erythroblastopenia and post-phlebotomy. Br J Haematol. 1980 Apr; 44(4):535-46. Papayannopoulou T, Vichinsky E, Stamatoyannopoulos G. PMID: 6155136.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    317. Anemia in the newborn period. Pediatr Ann. 1979 Jul; 8(7):416-34. Lubin B, Vichinsky E. PMID: 471553.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    318. Anemia associated with rheumatoid arthritis. J Pediatr. 1979 Apr; 94(4):678. Vichinsky EP. PMID: 430321.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    319. Immune response after splenectomy. Lancet. 1978 Jan 28; 1(8057):178-81. Sullivan JL, Ochs HD, Schiffman G, Hammerschlag MR, Miser J, Vichinsky E, Wedgwood RJ. PMID: 74605.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    320. Preparation and properties of a cell-free system from rat skin that catalyzes sterol biosynthesis. J Lipid Res. 1966 Jul; 7(4):501-10. Gaylor JL, Delwiche CV, Brady DR, Green AJ. PMID: 4290536.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    321. Guidelines for the Management of Non Tranfusion Dependent Thalassemia (NTDT). Thalassemia International Federation, 2013. Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V.View Publication.
    Elliott's Networks
    Concepts (988)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (53)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑